Colorectal Cancer: Predicting Prognosis for Patients and Probands Using Immunohistochemistry

Khurana, Vikas; Stollman, Neil; Rogers, Arvey I.
October 2000
American Journal of Gastroenterology;Oct2000, Vol. 95 Issue 10, p2981
Academic Journal
Discusses research being done on management strategy for colorectal cancer. Reference to a study by L. Cawkwell, S. Gray, H. Murgatroyd et al., published in the 1999 issue of the "Gut"; Imunohistochemical method used in detecting replication error positive colorectal cancer; Genetic components of colorectal cancer; Cause of hereditary nonpolyposis colorectal cancer.


Related Articles

  • Molecular Detection of Micrometastases: Science on Stage. Guan, Rong J.; Van Dam, Jacques; Johnson, David // American Journal of Gastroenterology;Oct1999, Vol. 94 Issue 10, p3062 

    Colorectal cancer is the most common gastrointestinal malignancy affecting approximately one person in 20 in the United States. Dissemination of tumor to locoregional lymph nodes is an important prognostic factor. Five-year survival drops from 80% in patients with TNM stage II disease (no...

  • CD44v6 is not relevant in colorectal tumour progression. Morrin, M.; Delaney, P. V. // International Journal of Colorectal Disease;Jan2002, Vol. 17 Issue 1, p30 

    Background and aims: There is a lack of consensus regarding the role of CD44 variants in colorectal cancer, with conflicting reports regarding their expression and correlation with prognosis. We investigated the expression and prognostic significance of CD44v6 protein in our series of colorectal...

  • Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas. Hashimoto, Yosuke; Skacel, Marek; Lavery, Ian C.; Mukherjee, Abir L.; Casey, Graham; Adams, Josephine C. // BMC Cancer;2006, Vol. 6, p241 

    Background: Fascin is an actin bundling protein with roles in the formation of cell protrusions and motility of mesenchymal and neuronal cells. Fascin is normally low or absent from epithelia, but is upregulated in several epithelial neoplasms where it may contribute to an invasive phenotype....

  • Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen. Caiyun Liu; Bin Dong; Aiping Lu; Like Qu; Xiaofang Xing; Lin Meng; Jian Wu; Shi, Y. Eric; Chengchao Shou // BMC Cancer;2010, Vol. 10, p356 

    Background: Synuclein gamma (SNCG), initially identified as a breast cancer specific gene, is aberrantly expressed in many different malignant tumors but rarely expressed in matched nonneoplastic adjacent tissues. In this study, we investigated the prognostic potential of SNCG in colon cancer...

  • Pregnancy does not influence colonic polyp multiplicily but may modulate upper gastrointestinal disease in patients with FAP. Suraweera, Nirosha; Latchford, Andrew; McCart, Amy; Rogers, Pauline; Spain, Sarah; Sieber, Oliver; Phillips, Robin; Tomlinson, Ian; Silver, Andrew // Journal of Medical Genetics;Aug2007, Vol. 44 Issue 8, p541 

    Background: Reproductive factors have been shown by epidemiology studies to alter colorectal cancer risk in women. Familial adenomatous polyposis (FAP) patients carry a germ- line adenomatous polyposis coli (ARC) mutation predisposing to multiple adenoma formation in the intestine. The Mm mouse...

  • MicroRNA expression profiling of specific cells in complex archival tissue stained by immunohistochemistry. Schuster, Claudia; Budczies, Jan; Faber, Claudius; Kirchner, Thomas; Hlubek, Falk // Laboratory Investigation (00236837);Jan2011, Vol. 91 Issue 1, p157 

    Global implementation of molecular diagnostics in modern pathology has been limited by the use of formalin-fixed, paraffin-embedded (FFPE) tissues in current routine diagnostic procedures because of modification and degradation of nucleic acids and protein molecules. In particular, molecular...

  • P53 Protein Immunohistochemical Expression in Colonic Adenomas With and Without Associated Carcinoma. Saleh, Husain A.; Aburashed, Ahmad; Bober, Paula; Tabaczka, Pamela // American Journal of Gastroenterology;Jun1998, Vol. 93 Issue 6, p980 

    Objectives: P53 protein immunohistochemical (IHC) expression was investigated in a series of colonic adenomas and carcinomas to determine the p53 immunohistochemical expression of adenomas in general compared with carcinomas, the difference in staining pattern between adenomas with associated...

  • COX-2, inflammatory secreted PLA2, and cytoplasmic PLA2 protein expression in small bowel adenocarcinomas compared with colorectal adenocarcinomas. Wendum, Dominique; Svrcek, Magali; Rigau, Valérie; Boëlle, Pierre-Yves; Sebbagh, Nicole; Parc, Rolland; Masliah, Joëlle; Trugnan, Germain; Fléjou, Jean-François; Rigau, Valérie; Boëlle, Pierre-Yves; Masliah, Joëlle; Fléjou, Jean-François // Modern Pathology;Feb2003, Vol. 16 Issue 2, p130 

    Cyclooxygenase-2 (COX-2), human synovial inflammatory secreted phospholipase A2 (sPLA2) and cytoplasmic phospholipase A2 (cPLA2) are involved in eicosanoid production and also seem to participate in colorectal tumorigenesis. As there are no data regarding these enzymes in human small bowel...

  • Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays. Moskaluk, Christopher A.; Zhang, Hong; Powell, Steven M.; Cerilli, Lisa A.; Hampton, Garret M.; Frierson, Henry F.; Jr.; Frierson, Henry F Jr // Modern Pathology;Sep2003, Vol. 16 Issue 9, p913 

    Cdx2 has been identified as a marker of colon cancer in RNA-profiling experiments. We show here that the detection of Cdx2 protein by immunohistochemistry correlates well with RNA transcript levels as detected by oligonucleotide microarrays. Using tissue microarrays containing most normal tissue...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics